Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Maryland Cigarette Restitution Fund | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Behavioral Weight Loss for Overweight and Obese Cancer Survivors in Maryland: A Demonstration Project
The objective of the ASPIRE Project is to design, implement, and evaluate a real-world, lifestyle-based, support for overweight or obese cancer survivors in both urban and rural areas of Maryland. The project will provide three options of support to encourage lifestyle change to achieve and maintain a healthy weight for cancer survivors:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Self-Directed Weight Loss with year-long weight tracking | Other | Written Weight Loss Material. |
|
| App-Directed Weight Loss with year-long weight tracking | Other | Smart phone Weight Loss App. |
|
| Coach-Directed Weight Loss with year-long weight tracking | Other | Behavioral Lifestyle Weight Loss Intervention with Smart phone Weight Loss App. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Written Weight Loss Material | Behavioral | Participants will receive written weight loss material by email. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Weight change at 6 months in Coach-Directed Program | Evaluate the "effectiveness" of the Coach-Directed weight loss programs in a real world setting by examining weight change [in kilograms (kg)] at 6-months. | Baseline and 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Weight change at 6 months in Self-Directed and App-Directed Weight Loss Programs | Evaluate the "effectiveness" of the Self-Directed and App-Directed weight loss programs in a real world setting by examining weight change [in kilograms (kg)] at 6-months. | Baseline and 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Program participation as assessed by participant enrollment | Examine the enrollment in each program as a measure of program participation. | End of enrollment, up to 2 years |
| Adoption of weight loss program activities as assessed by app use frequency |
Inclusion Criteria:
Additional criteria for participants in weight tracking (self-directed or app directed)
Additional criteria for App-Directed Program:
Additional Criteria for Coach-Directed Weight Loss Program
willingness to lose weight by changing diet and physical activity habits
willingness to track weight, diet and physical activity
willingness to record/transmit quarterly weights for 12 months
smart phone for personal use
data plan/Internet to support daily use of weight loss app*
willingness to complete coaching calls (12 weekly calls and 3 monthly calls)
sufficient call plan to support coaching calls
Exclusion Criteria:
Additional exclusion criteria for participants in weight tracking and/or Coach-Directed Program
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jessica Yeh, Ph.D. | Johns Hopkins University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Johns Hopkins ProHealth | Baltimore | Maryland | 21207 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38865181 | Derived | Jerome GJ, Appel LJ, Bunyard L, Dalcin AT, Durkin N, Charleston JB, Kanarek NF, Carducci MA, Wang NY, Yeh HC. Behavioral Weight Loss Programs for Cancer Survivors Throughout Maryland: Protocol for a Pragmatic Trial and Participant Characteristics. JMIR Res Protoc. 2024 Jun 12;13:e54126. doi: 10.2196/54126. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Weight Loss App | Behavioral | Participants will receive written weight loss material as well as instructions for using a free weight loss app on their phone or computer. |
|
| Behavioral Lifestyle Weight Loss Intervention (Coaching) | Behavioral | Participants will receive weekly coaching phone calls to encourage regular dietary, exercise, and self-monitoring practices which encourage gradual, healthy weight loss. |
|
Evaluate the "adoption" of the App-Directed Weight Loss Program and Coach-Directed Weight Loss Program by examining app-use frequency at six months.
| 6 months |
| Implementation of weight loss program as assessed by a participant survey | Evaluate the implementation of the Coach-Directed Weight Loss Program through a participant survey. | 6 months |
| Weight change at 12 months by program | Evaluate the "maintenance" of the Self-Directed, App-Directed and Coach-Directed weight loss programs in a real world setting by examining weight change [in kilograms (kg)] at 12-months by program. | Baseline and 12 months |
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| D011471 | Prostatic Neoplasms |
| D008545 | Melanoma |
| D016889 | Endometrial Neoplasms |
| D005706 | Gallbladder Neoplasms |
| D012004 | Rectal Neoplasms |
| D007680 | Kidney Neoplasms |
| D001749 | Urinary Bladder Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D005834 | Genital Neoplasms, Male |
| D014565 | Urogenital Neoplasms |
| D005832 | Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D011469 | Prostatic Diseases |
| D052801 | Male Urogenital Diseases |
| D018358 | Neuroendocrine Tumors |
| D017599 | Neuroectodermal Tumors |
| D009373 | Neoplasms, Germ Cell and Embryonal |
| D009370 | Neoplasms by Histologic Type |
| D009380 | Neoplasms, Nerve Tissue |
| D018326 | Nevi and Melanomas |
| D012878 | Skin Neoplasms |
| D014594 | Uterine Neoplasms |
| D005833 | Genital Neoplasms, Female |
| D014591 | Uterine Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D001661 | Biliary Tract Neoplasms |
| D004067 | Digestive System Neoplasms |
| D001660 | Biliary Tract Diseases |
| D004066 | Digestive System Diseases |
| D005705 | Gallbladder Diseases |
| D015179 | Colorectal Neoplasms |
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D005767 | Gastrointestinal Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |
| D014571 | Urologic Neoplasms |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D001745 | Urinary Bladder Diseases |
Not provided
Not provided